Online-Event
Healthtech Innovation Insight: Personalized medication made in Germany: The path to certification as a Class IIb medical device
23. September 2026
15:30 - 16:30
insight_iStock©dontree_m_1460400264_ret_blau,
How genetics determines drug efficacy: PGXperts' path to IIb certification and the hurdles of personalized medication.
FHIR is increasingly becoming the common denominator for the exchange of clinical data. The presentation gives an understandable introduction to FHIR against the background of older standards and proprietary interfaces and shows which problem FHIR solves in modern healthcare systems. It also highlights the growing practical importance of FHIR in the context of regulatory developments such as DiGA, European interoperability efforts and EHDS. Using concrete data and API examples, it will become tangible how FHIR is structured, how resources are modeled and what role terminologies such as SNOMED CT and LOINC play for semantic interoperability.
Till Gerken is CTO at Evoleen, a service provider for the development of digital health applications.
Register now!
You can find all other Healthtech Innovation Insights here.
Specialist contact person
Organizational contact person